← Back to Clinical Trials
Recruiting NCT06467045

NCT06467045 Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06467045
Status Recruiting
Phase
Sponsor Sisli Hamidiye Etfal Training and Research Hospital
Condition Sedation
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2024-06-24
Primary Completion 2024-09-21

Trial Parameters

Condition Sedation
Sponsor Sisli Hamidiye Etfal Training and Research Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 0 Days
Max Age 16 Years
Start Date 2024-06-24
Completion 2024-09-21
Interventions
Pediatric patients who received sedation for magnetic resonance imaging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Introduction:The application of anesthesia outside the operating room for pediatric patients has increased in recent years. For diagnostic and treatment follow-up purposes, magnetic resonance imaging (MRI) requires the pediatric patient to remain still, necessitating sedation. The study aimed to determine the frequency of adverse effects and influencing factors in pediatric patients undergoing sedation during MRI. Methods: Between 19.06.2024 and 16.09.2024, estimated 500 pediatric patients who underwent MRI under sedation will be prospectively observed. All non-intubated patients under the age of 16 will be included in the study. The demographic data, comorbidities, and medications of the patients, the procedures performed, the anesthetic drugs used, the expertise duration of the anesthesiologist, and the adverse effects encountered will be recorded.

Eligibility Criteria

Inclusion Criteria: * All non-intubated patients under the age of 16 were included in the study. Exclusion Criteria: * Intubated pediatric patients or older than 16 years patients were excluded.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology